Back to today’s briefing

Story perspectives

Fifth Circuit Upholds Medicare Drug Price Negotiations

8/29/2026

22 2 Full Breakdown

Summary

Story summary

The U.S. Fifth Circuit Court of Appeals upheld the Medicare drug-price negotiation program, rejecting PhRMA’s constitutional challenge.
Judge Leslie Southwick ruled manufacturers lack a protected right to set Medicare prices because participation is voluntary.
Seniors will continue receiving lower out-of-pocket costs while related lawsuits proceed.
PhRMA said it is reviewing the decision and may seek a Supreme Court appeal.

1 of 1

Story summary

The U.S. Fifth Circuit Court of Appeals upheld the Medicare drug-price negotiation program, rejecting PhRMA’s constitutional challenge.
Judge Leslie Southwick ruled manufacturers lack a protected right to set Medicare prices because participation is voluntary.
Seniors will continue receiving lower out-of-pocket costs while related lawsuits proceed.
PhRMA said it is reviewing the decision and may seek a Supreme Court appeal.